We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 2,004

CA State Campaign Ads To Require Greater Disclosure of Funding; Cities & Counties Could Go Deeper
  • Nossaman LLP
  • USA
  • October 12 2017

The California DISCLOSE Act (Assembly Bill 249), was signed into law on October 7, 2017. It overhauls portions of California's Political Reform Act

UPDATE: New York City Commission on Human Rights Releases Additional Guidance and FAQs on the New York City Salary History Law
  • Seyfarth Shaw LLP
  • USA
  • October 12 2017

New York City's Salary History Law goes into effect on October 31, 2017. It will prohibit covered employers from inquiring about a candidate's salary

Expanded Panel Ratifies Post-Petition Disclaimer As Legitimate CBM Eligibility Strategy
  • Jones Day
  • USA
  • October 11 2017

An expanded panel at the PTAB has found that post-Petition claim cancellation is a legitimate strategy for patent owners to avoid CBM jurisdiction. In

Broadest Reasonable Interpretation Guidance During Prosecution
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • September 28 2017

Even though the USPTO has been using the broadest reasonable interpretation (BRI) for over 100 years, guidance by the Federal Circuit is still needed

Federal Circuit Orders En Banc Rehearing of Decision Awarding USPTO Attorneys’ Fees in District Court Appeals from USPTO
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • September 8 2017

In NantKwest, Inc. v. Matal, 860 F.3d 1352 (Fed. Cir. 2017), a Federal Circuit panel determined that 35 U.S.C. 145 permits awarding a pro-rata share

FDA Authorizes Qualified Health Claim Linking Early Peanut Introduction and Reduced Risk of Developing Peanut Allergy
  • Keller and Heckman LLP
  • USA
  • September 8 2017

A health claim characterizes the relationship between a substance and its ability to reduce the risk of a disease or health-related condition (see 21

DACA Program Ending, but Work Permits Remain Valid
  • Duane Morris LLP
  • USA
  • September 6 2017

On September 5, 2017, the Department of Homeland Security (Department) announced that the Deferred Action for Childhood Arrivals (DACA) program will

New York City Finalizes Rules to Interpret the Fair Chance Act
  • Epstein Becker Green
  • USA
  • September 1 2017

On August 5, 2017, the final rules (“Final Rules”) interpreting New York City’s Fair Chance Act (“FCA”) took effectnearly 18 months after the

Everything Else You Need to Know About New York City’s FCANew Rules Effective August 5, 2017
  • Ogletree Deakins
  • USA
  • August 21 2017

New York City has issued new rules interpreting the City's Fair Chance Act (FCA). These rules, which went into effect on August 5, 2017, provide

Avoiding Accidental Contracts By Email: A Tech-Centric Point of View
  • Vinson & Elkins LLP
  • USA
  • August 1 2017

In today’s fast-paced business environment, email is indispensable. But its speed and informality can lead to the inadvertent use of contract-forming